处方药物审查：odevixibat。
Formulary Drug Review: Odevixibat.
作者信息
Levien Terri L, Baker Danial E
机构信息
Washington State University, Spokane, WA, USA.
出版信息
Hosp Pharm. 2023 Apr;58(2):125-133. doi: 10.1177/00185787211069036. Epub 2022 Feb 8.
Each month, subscribers to receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of publishes selected reviews in this column. For more information about , contact Wolters Kluwer customer service at 866-397-3433.
每月，订阅者会收到5至6篇有充分文献依据的专论，内容涉及新发布的药物或处于3期临床试验后期的药物。这些专论面向药学与治疗学委员会。订阅者还会每月收到1页的关于对议程以及药房/护理在职培训有用的药物的简要专论。每月还会提供一份全面的目标药物利用评估/药物使用评估（DUE/MUE）。订阅后，专论可供订阅者在线获取。专论可定制以满足机构的需求。通过合作，出版方会在本专栏发表精选评论。如需了解更多关于……的信息，请致电866 - 397 - 3433联系威科集团客户服务部。
Zotero 插件